Építés alatt – nem éles oldal
Belépés
Fut, nem toboroz2. fázis

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

A legfontosabb adatok

Ki végzi
Ohio State University
Hol
Boca Raton, Columbus, Indianapolis, Lowell, Maywood és Miami (Egyesült Államok)Mind a 6 helyszín megnézéseMég 1 másik országban, 1 helyszínen
Azonosító
Állapot
Fut, nem toboroz
Fázis
2. fázis
Résztvevők
37 fő vett részt
Kezdés
2020. aug. 28.
Várható befejezés
2026. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Low dose radiation 35 cGy
  • High dose radiation 100 cGy
A regiszteradat frissítve
2026. április 16.

Ki vehet részt

Életkor
50 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Laboratory-confirmed diagnosis of SARS-CoV-2 pneumonia
  • Currently hospitalized with COVID-19
  • Symptomatic fever, cough and/or dyspnea for < 9 days
  • Patient or legal/authorized representative can understand and sign the study informed consent document
  • Able to be positioned on a linear-accelerator couch for Radiation Therapy delivery
  • And at least one of the following risk factors for significant pulmonary compromise:; Fever > 102 degrees Fahrenheit during index admission; Respiratory rate of ≥ 26 / minute within 24 hours of screening; SpO2 ≤ 95% on room air within 24 hours of screening; Any patient requiring 4 L/min oxygen therapy to maintain SpO2 >93% within 24 hours of screening; Ratio of partial pressure of arterial oxygen to fraction of inspired air < 320
  • Patients may be enrolled on this trial while concurrently enrolled on other COVID-19 clinical trials

Ki nem vehet részt

  • Prior thoracic radiotherapy, with the exception of the following:; Breast or post-mastectomy chest wall radiation (without regional nodal irradiation) may be included at the discretion of the site primary investigator, and; Thoracic skin radiation therapy (without regional nodal irradiation) is allowed
  • Known prior systemic use of the following drugs: Bleomycin, Carmustine, Methotrexate, Busulfan, Cyclophosphamide, or Amiodarone
  • History of recent or current malignancy receiving any cytotoxic chemotherapy or immunotherapy within the past 6 months
  • Inability to undergo radiotherapy for any other medical or cognitive issues
  • Known hereditary syndrome with increased sensitivity to radiotherapy, including ataxia-telangiectasia, xeroderma pigmentosum, and Nijmegen Breakage Syndrome
  • History of or current diagnosis of pulmonary fibrosis, or an alternative pulmonary condition responsible for significant lung compromise at the discretion of the site primary investigator
  • History of lung lobectomy or pneumonectomy
  • Known history of pulmonary sarcoidosis, Wegener's granulomatosis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, polymyositis/dermatomyositis, Sjögren's syndrome, mixed connective tissue disease, Churg-Strauss syndrome, Goodpasture's syndrome, or ankylosing spondylitis
  • Symptomatic congestive heart failure within the past 6 months including during current hospitalization
  • History of bone marrow transplantation
  • History of any solid organ transplant (renal, cardiac, liver, lung) requiring immunosuppressive therapy
  • Currently requiring mechanical ventilation
  • Females who are pregnant or breast feeding

Helyszínek itt: Egyesült Államok

Még 1 másik országban, 1 helyszínen

  • Boca Raton Regional Hospital -Lynn Cancer InstituteBoca Raton, Egyesült Államok
  • Ohio State University James Cancer HospitalColumbus, Egyesült Államok
  • Indiana University School of MedicineIndianapolis, Egyesült Államok
  • Lowell General Hospital Cancer CenterLowell, Egyesült Államok
  • Loyola University ChicagoMaywood, Egyesült Államok
  • Miami Cancer InstituteMiami, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

Low doses of radiation in the form of chest x-rays has been in the past to treat people with pneumonia. This treatment was thought to reduce inflammation and was found to be effective without side effects. However, it was an expensive treatment and was eventually replaced with less expensive treatment options like penicillin.

A teljes eredeti leírásKevesebb

The COVID-19 virus has emerged recently, causing high rates of pneumonia in people. The authors believe that giving a small dose of radiation to the lungs may reduce inflammation and neutralize the pneumonia caused by COVID-19. For this study, the x-ray given is called radiation therapy. Radiation therapy uses high-energy X-ray beams from a large machine to target the lungs and reduce inflammation. Usually, it is given at much higher doses to treat cancers.

The purpose of this study is to find out if adding a single treatment of low-dose x-rays to the lungs might reduce the amount of inflammation in the lungs from COVID-19 infection, which could reduce the need for a ventilator or breathing tube.

A vizsgálat 3 csoportja

  • Low radiation armA vizsgált kezelés

    A single dose of 35 cGY delivered to the whole thorax

    Kezelés: Low dose radiation 35 cGy

  • High radiation armA vizsgált kezelés

    A single dose of 100 cGY delivered to the whole thorax

    Kezelés: High dose radiation 100 cGy

  • Control armNincs vizsgálati kezelés, összehasonlításként

    Patients will receive no radiation therapy but will have research samples collected and best supportive care

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Phase II Protocol of Low-Dose Whole Thorax Megavoltage Radiotherapy for Patients With SARS-COV-2 Pneumonia
Publikációk
A regiszteradat frissítve
2026. április 16.